These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 27693733
41. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Kuca K, Cabal J, Kassa J. Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060 [Abstract] [Full Text] [Related]
42. Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach. Worek F, Wille T, Aurbek N, Eyer P, Thiermann H. Toxicol Appl Pharmacol; 2010 Dec 15; 249(3):231-7. PubMed ID: 20888357 [Abstract] [Full Text] [Related]
43. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties. Bhattacharjee AK, Kuca K, Musilek K, Gordon RK. Chem Res Toxicol; 2010 Jan 15; 23(1):26-36. PubMed ID: 20028185 [Abstract] [Full Text] [Related]
44. Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity. Artursson E, Andersson PO, Akfur C, Linusson A, Börjegren S, Ekström F. Biochem Pharmacol; 2013 May 01; 85(9):1389-97. PubMed ID: 23376121 [Abstract] [Full Text] [Related]
45. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose. Shih TM, Skovira JW, O'Donnell JC, McDonough JH. Toxicol Mech Methods; 2009 Sep 01; 19(6-7):386-400. PubMed ID: 19778239 [Abstract] [Full Text] [Related]
46. In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase. Jun D, Musilova L, Musilek K, Kuca K. Int J Mol Sci; 2011 Sep 01; 12(3):2077-87. PubMed ID: 21673941 [Abstract] [Full Text] [Related]
47. Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase. Sahu AK, Sharma R, Gupta B, Musilek K, Kuca K, Acharya J, Ghosh KK. Toxicol Mech Methods; 2016 Jun 01; 26(5):319-26. PubMed ID: 27101948 [Abstract] [Full Text] [Related]
48. New Cinchona Oximes Evaluated as Reactivators of Acetylcholinesterase and Butyrylcholinesterase Inhibited by Organophosphorus Compounds. Katalinić M, Zandona A, Ramić A, Zorbaz T, Primožič I, Kovarik Z. Molecules; 2017 Jul 22; 22(7):. PubMed ID: 28737687 [Abstract] [Full Text] [Related]
49. Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase. Jończyk J, Kukułowicz J, Łątka K, Malawska B, Jung YS, Musilek K, Bajda M. Biomolecules; 2021 Jan 27; 11(2):. PubMed ID: 33513955 [Abstract] [Full Text] [Related]
50. Amidine-oximes: reactivators for organophosphate exposure. Kalisiak J, Ralph EC, Zhang J, Cashman JR. J Med Chem; 2011 May 12; 54(9):3319-30. PubMed ID: 21438612 [Abstract] [Full Text] [Related]
51. Structural requirements of acetylcholinesterase reactivators. Kuca K, Juna D, Musilek K. Mini Rev Med Chem; 2006 Mar 12; 6(3):269-77. PubMed ID: 16515465 [Abstract] [Full Text] [Related]
52. Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase. de Koning MC, Horn G, Worek F, van Grol M. Eur J Med Chem; 2018 Sep 05; 157():151-160. PubMed ID: 30096649 [Abstract] [Full Text] [Related]
53. Exploring the physicochemical properties of oxime-reactivation therapeutics for cyclosarin, sarin, tabun, and VX inactivated acetylcholinesterase. Esposito EX, Stouch TR, Wymore T, Madura JD. Chem Res Toxicol; 2014 Jan 21; 27(1):99-110. PubMed ID: 24443939 [Abstract] [Full Text] [Related]
54. Universality of Oxime K203 for Reactivation of Nerve Agent-Inhibited AChE. Kuca K, Hrabinova M, Jun D, Musilek K, Penhaker M, Krejcar O, Soukup O. Med Chem; 2015 Jan 21; 11(7):683-6. PubMed ID: 25845909 [Abstract] [Full Text] [Related]
55. Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes. Zorbaz T, Malinak D, Kuca K, Musilek K, Kovarik Z. Chem Biol Interact; 2019 Jul 01; 307():16-20. PubMed ID: 31004594 [Abstract] [Full Text] [Related]
56. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Antonijevic B, Stojiljkovic MP. Clin Med Res; 2007 Mar 01; 5(1):71-82. PubMed ID: 17456837 [Abstract] [Full Text] [Related]
57. New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarin. Hrabinova M, Musilek K, Jun D, Kuca K. J Enzyme Inhib Med Chem; 2006 Oct 01; 21(5):515-9. PubMed ID: 17194020 [Abstract] [Full Text] [Related]
58. Reactivation of DFP- and paraoxon-inhibited acetylcholinesterases by pyridinium oximes. Oh KA, Park NJ, Park NS, Kuca K, Jun D, Jung YS. Chem Biol Interact; 2008 Sep 25; 175(1-3):365-7. PubMed ID: 18565503 [Abstract] [Full Text] [Related]
59. Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor. Rosenberg YJ, Mao L, Jiang X, Lees J, Zhang L, Radic Z, Taylor P. Chem Biol Interact; 2017 Aug 25; 274():50-57. PubMed ID: 28693885 [Abstract] [Full Text] [Related]
60. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes. Worek F, Wille T, Koller M, Thiermann H. Chem Biol Interact; 2013 Mar 25; 203(1):125-8. PubMed ID: 22827894 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]